Biodesix, Inc.
General ticker "BDSX" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $1.7B (TTM average)
Biodesix, Inc. does not follow the US Stock Market performance with the rate: -11.7%.
Estimated limits based on current volatility of 3.4%: low 7.99$, high 8.54$
Factors to consider:
- Total employees count: 273 (+25.8%) as of 2024
- Top business risk factors: Net losses and future profitability, Market acceptance of diagnostic tests, Third-party risks, Climate change and natural disasters, Regulatory and compliance
- Current price 22.7% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [11.04$, 33.36$]
- 2025-12-31 to 2026-12-31 estimated range: [6.94$, 21.72$]
Financial Metrics affecting the BDSX estimates:
- Negative: with PPE of -83.4 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -25.72 <= 0.33
- Positive: 18.93 < Shareholder equity ratio, % of 21.47 <= 41.86
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of -0.79 <= -0.15
- Positive: Inventory ratio change, % of -3.09 <= -0.75
Short-term BDSX quotes
Long-term BDSX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $38.21MM | $49.09MM | $71.32MM |
| Operating Expenses | $88.80MM | $90.43MM | $105.82MM |
| Operating Income | $-50.59MM | $-41.34MM | $-34.50MM |
| Non-Operating Income | $-14.86MM | $-10.80MM | $-8.43MM |
| Interest Expense | $8.07MM | $9.54MM | $8.26MM |
| R&D Expense | $13.10MM | $9.99MM | $9.56MM |
| Income(Loss) | $-65.45MM | $-52.15MM | $-42.93MM |
| Profit(Loss)* | $-65.45MM | $-52.15MM | $-42.93MM |
| Stockholders Equity | $20.61MM | $4.58MM | $20.88MM |
| Inventory | $1.40MM | $1.40MM | $0.00MM |
| Assets | $92.91MM | $99.10MM | $97.24MM |
| Operating Cash Flow | $-44.97MM | $-22.87MM | $-48.65MM |
| Capital expenditure | $3.53MM | $23.06MM | $3.23MM |
| Investing Cash Flow | $-3.53MM | $-23.06MM | $-3.44MM |
| Financing Cash Flow | $58.88MM | $29.13MM | $52.05MM |
| Earnings Per Share** | $-31.09 | $-12.70 | $-6.62 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.